Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

Two first analyses of our clinical trial on TIL as adjuvant therapy for melanoma were published in 2002 and 2007. We present here an update of the clinical results after a 17-year median followup. In this trial, disease-free patients were randomly assigned to receive either TIL/IL-2 or IL-2. The rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Khammari, Amir, Knol, Anne-Chantal, Nguyen, Jean-Michel, Bossard, Céline, Denis, Marc-Guillaume, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Bercegeay, Sylvain, Dréno, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987883/
https://www.ncbi.nlm.nih.gov/pubmed/24741578
http://dx.doi.org/10.1155/2014/186212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987883/
https://www.ncbi.nlm.nih.gov/pubmed/24741578
http://dx.doi.org/10.1155/2014/186212

Ejemplares similares